145 related articles for article (PubMed ID: 7891851)
1. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons.
Hurd YL; Pristupa ZB; Herman MM; Niznik HB; Kleinman JE
Neuroscience; 1994 Nov; 63(2):357-62. PubMed ID: 7891851
[TBL] [Abstract][Full Text] [Related]
2. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
Haber SN; Ryoo H; Cox C; Lu W
J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones.
Augood SJ; Westmore K; McKenna PJ; Emson PC
Brain Res Mol Brain Res; 1993 Dec; 20(4):328-34. PubMed ID: 7906851
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
[TBL] [Abstract][Full Text] [Related]
6. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
Szot P; White SS; Veith RC; Rasmussen DD
Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
[TBL] [Abstract][Full Text] [Related]
7. Prenatal ontogeny of D2 dopamine receptor and dopamine transporter gene expression in the rat mesencephalon.
Tison F; Normand E; Bloch B
Neurosci Lett; 1994 Jan; 166(1):48-50. PubMed ID: 7910679
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
Han M; Huang XF; Deng C
Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical localization of the dopamine transporter in human brain.
Ciliax BJ; Drash GW; Staley JK; Haber S; Mobley CJ; Miller GW; Mufson EJ; Mash DC; Levey AI
J Comp Neurol; 1999 Jun; 409(1):38-56. PubMed ID: 10363710
[TBL] [Abstract][Full Text] [Related]
11. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.
Counihan TJ; Penney JB
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):164-9. PubMed ID: 9703165
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
Rothblat DS; Schroeder JA; Schneider JS
J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
[TBL] [Abstract][Full Text] [Related]
13. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions.
Frohna PA; Neal-Beliveau BS; Joyce JN
Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter mRNA: dense expression in ventral midbrain neurons.
Shimada S; Kitayama S; Walther D; Uhl G
Brain Res Mol Brain Res; 1992 May; 13(4):359-62. PubMed ID: 1352613
[TBL] [Abstract][Full Text] [Related]
16. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia.
Ballmaier M; Zoli M; Leo G; Agnati LF; Spano P
Eur J Neurosci; 2002 Apr; 15(7):1197-205. PubMed ID: 11982630
[TBL] [Abstract][Full Text] [Related]
17. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.
Prasad BM; Amara SG
J Neurosci; 2001 Oct; 21(19):7561-7. PubMed ID: 11567046
[TBL] [Abstract][Full Text] [Related]
18. Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice.
Tseng KY; Roubert C; Do L; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gershanik OS; Murer MG; Giros B; Raisman-Vozari R
Brain Res Mol Brain Res; 2000 Aug; 80(1):1-6. PubMed ID: 11039723
[TBL] [Abstract][Full Text] [Related]
19. Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA.
Weiss-Wunder LT; Chesselet MF
J Comp Neurol; 1991 Jan; 303(3):478-88. PubMed ID: 1672536
[TBL] [Abstract][Full Text] [Related]
20. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
Shepard JD; Chuang DT; Shaham Y; Morales M
Psychopharmacology (Berl); 2006 May; 185(4):505-13. PubMed ID: 16555063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
